Amgen’s Clinical Trial Setback With Colon Cancer Drug, Vectibix

Amgen's clinical trial of its cancer drug, Vectibix, has also found potential safety issues.  More on this from Business Week.
March 23, 2007
Amgen's clinical trial of its cancer drug, Vectibix, has also found potential safety issues.  More on this from Business Week.

About the Author

pharmamanufacturing

pharmamanufacturing

Sign up for our eNewsletters
Get the latest news and updates